Visual Abstracts

Primary Immunodeficiency

For Public Health Programs and  Healthcare Providers:

Visual Abstract for Primary immunodeficiency and increased COVID-19 outcome severity : What is primary immunodeficiency? Primary immunodeficiency (PI) is a group of genetic diseases that increase susceptibility to infectious diseases.  image of a gloved hand holding a test tube   Odds ratios (95% confidence interval) for COVID-19 outcomes between PI and non-PI patients  Hospitalization arrow to 2.36 (1.87-2.98)  ICU admission arrow to 1.53 (1.19-1.96)  Invasive mechanical ventilation arrow to 1.41 (1.15-1.72)  Death arrow to 1.37 (1.08-1.74)  Risk for adverse COVID-19 outcomes These findings can inform people with PI and their healthcare providers about the risk for adverseCOVID-19 outcomes.  image of a COVID-19 virus  Severity Outcomes Among Adult Patients with Primary Immunodeficiency and COVID-19 Seen in Emergency Departments, United States, April 2020–August 2021, J Clin Med. 2023 May 17;12(10):3516.

Cardiovascular Disease

For Public Health Programs and  Healthcare Providers:

Millions At Risk For Cardiovascular Disease Can Be Identified By Family History

For the General Public:

Act On Your Family History Of Heart Attacks

Hereditary Breast and Ovarian Cancer

For Public Health Programs and  Healthcare Providers:

Visual Abstract: Nonmetropolitan Areas Have Lower BRCA Testing Rates and  Preventive Services Uptake than Metropolitan Areas in the United States

Familial Hypercholesterolemia

For Healthcare Providers – Diagnosis:

Visual Abstract for Diagnose Familial Hypercholesterolemia (FH) Early

For Healthcare Providers – Treatment:

visual abstract for Treating Familial Hypercholesterolemia to Prevent Heart Disease

For the General Public – Finding FH early:

visual abstract for finding Familial Hypercholesterolemia (FH) early

For the General Public – Treatment:

visual abstract for Treating Familial Hypercholesterolemia to Prevent Heart Disease